What is thrombocytopenia, the rare blood condition possibly linked to the AstraZeneca vaccine?

By Anthony Zulli, Associate professor, Victoria University
Maja Husaric, Senior Lecturer; MD, Victoria University
Maximilian de Courten, Professor in Global Public Health and Director of the Mitchell Institute, Victoria University
Vasso Apostolopoulos, Professor of Immunology and Associate Provost, Research Partnerships, Victoria University

Scientists have called it "vaccine-induced prothrombotic immune thrombocytopenia", or VIPIT. The condition is characterised by a shortage of platelets in the blood.

Read complete article

~	Fallout: an expertly crafted TV adaptation that manages to incorporate some of the best elements of gameplay

~	Extraordinary Vietnam fraud case exposes the inherent vulnerabilities of banks

~	AI-powered ‘deep medicine’ could transform healthcare in the NHS and reconnect staff with their patients

~	Ukraine war: Putin’s plan to fire up Zaporizhzhia power plant risks massive nuclear disaster

~	How Israel continues to censor journalists covering the war in Gaza

~	Rishi Sunak wants to cut the cost of ‘sicknote’ Britain. But we’ve found a strong economic case for benefits

~	New EU trade rules could put poor countries in a billion dollar ‘green squeeze’

~	The UK’s Climate Change Act, once the envy of the world, faces a stress test

~	The weather experiment that really flooded Dubai

~	Economic growth tops the priority list for Canadian policymakers — here’s why